Biomarkers are a cornerstone of integrated CVD diagnostics for improving patient outcomes. Check out this new clinicians’ guide with the essentials on cardiac testing.
For thousands of women diagnosed with metastatic breast cancer each year, measuring Serum HER-2/neu is the only FDA-cleared method indicated for monitoring patients with metastatic breast cancer.